Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.0B | 2.9B | 2.7B | 2.6B |
| Cost of revenue | 1.5B | 1.5B | 1.4B | 1.4B |
| Gross profit | 1.5B | 1.4B | 1.3B | 1.2B |
| Operating expense | ||||
| Research & development | 306M | 297M | 289M | 303M |
| Selling general and admin | 918M | 865M | 798M | 1.0B |
| Other operating expenses | — | — | — | — |
| Operating income | 156M | 117M | 107M | -201M |
| Non operating interest income | ||||
| Income | 49M | 51M | 54M | 49M |
| Expense | — | — | — | — |
| Other income expense | -7M | 8M | -6M | -5M |
| Pretax income | 198M | 176M | 155M | -157M |
| Tax provision | 6M | 37M | -6M | 1M |
| Net income | 192M | 139M | 161M | -158M |
| Basic EPS | 0.5 | 0.3 | 0.4 | -0.4 |
| Diluted EPS | 0.4 | 0.3 | 0.4 | -0.4 |
| Basic average shares | 421.4M | 417.1M | 413.1M | 410.5M |
| Diluted average shares | 435.6M | 417.1M | 413.1M | 410.5M |
| EBITDA | 309M | 258M | 245M | -61M |
| Net income from continuing op. | 192M | 139M | 161M | -158M |
| Minority interests | 1M | 2M | 1M | 1M |
| Preferred stock dividends | — | — | — | — |